This is an IAPMD Professional Community Webinar, and the content is aimed at Health Care Professionals & Researchers. Patients with a special interest are welcome to attend but please note that the presentation will be clinical in nature and we are not able to answer questions about individual health concerns/circumstances. Patient tickets are available here >>
Despite the documented success of GnRH agonists for the treatment of treatment-resistant premenstrual dysphoric disorder (PMDD), many patients struggle to find providers who have sufficient knowledge of PMDD and its evidence-based treatments and/or who are comfortable treating PMDD after first-line treatment options have failed.
This session will highlight the barriers to initiating GnRH agonists for treatment-resistant premenstrual dysphoric disorder (PMDD) and offer practical solutions to address these barriers for providers who encounter patients with treatment-resistant PMDD but may not have the necessary expertise or comfort with providing evidence-based treatments.
This session will also include:
example patient and provider handouts,
screening tools,
treatment algorithms to help provide guidance for implementing GnRH agonists into practice amongst a broader scope of clinicians, including general psychiatrists.
Sο»Ώpeaker: Melissa Wagner, M.D., Ph.D.
Following residency, Dr. Wagner took an academic attending psychiatrist position as a reproductive psychiatrist and, through peer supervision and clinical and research collaborations, gained expertise in treating patients with mental illness during times of hormonal transitions. These times of hormone transition include prior to, during, and after pregnancy, mental health disorders related to hormone changes or the menstrual cycle, including perimenstrual dysphoric disorder (PMDD) and menopause, and mental health disorders related to or affecting fertility. Her triple board training serves as a significant asset in bridging the clinical gaps between reproductive psychiatry and family mental health. Dr. Wagner collaborates with internists, obstetricians, reproductive psychiatrists, and psychologists at both the University of Cincinnati and the University of Illinois with an academic focus that includes developing innovative care delivery models to help improve the diagnosis and treatment of reproductive-related mental illnesses and research involving PMDD, suicide risk, and neurosteroids. Finally, Dr. Wagner is clinically active in both psychiatry and pediatrics and serves as a supervising pediatrician within a Medicine-Pediatrics resident clinic at the University of Cincinnati and as the collaborative care reproductive and child psychiatrist in an innovative two-generation clinic within the internal medicine/pediatrics department at the University of Illinois in Chicago.
We are international and we know time zones can be confusing - to find what time this webinar will take place for you - click here.
TICKETS
Live webinar attendance is free to IAPMD Professional Community Members and you will automatically receive an invite. Membership includes two monthly webinars and exclusive networking opportunities for $10US/month. FREE for students!
Non-IAPMD Professional Community Members can purchase places at $15US per webinar if you are an established professional or $5 to students or patients. These funds will support IAPMD, a small but powerful nonprofit organization that will provide the social media visibility and staff support to sustain this new professional community.
The International Association for Premenstrual Disorders Clinical Advisory Board is staffed primarily by scientific experts who volunteer their time.
Join the IAPMD Professional Community Membership today for free access to previous webinars, networking events, resources, and more!